Ophthalmology and Vision Science

About us

The 8th World Congress on Ophthalmology and Vision Science, scheduled for July 20–21, 2027, in Rome, Italy, is an international scientific platform dedicated to advancing knowledge, research, clinical practice, and innovation in ophthalmology and vision science. The conference will focus on the theme “Advancing Vision Science: Innovations in Ophthalmic Diagnostics, Therapeutics & Patient Care,” highlighting the importance of scientific progress, precision-based approaches, and technological innovation in improving eye health. The conference will explore a broad range of topics, including clinical ophthalmology, retinal diseases, glaucoma, cataract, refractive surgery, corneal disorders, ocular surface disease, pediatric ophthalmology, neuro-ophthalmology, ocular imaging, and visual rehabilitation. Special attention will be given to emerging developments in ophthalmic diagnostics, innovative treatment strategies, artificial intelligence, digital ophthalmology, precision medicine, and advanced therapeutic approaches.

The conference will also provide a platform to discuss current challenges in ophthalmic practice, emerging research opportunities, and the integration of innovative technologies into routine eye care. Participants will have the opportunity to share clinical experiences, present scientific findings, and explore new approaches to the prevention, diagnosis, and management of vision-related disorders. The meeting aims to encourage scientific collaboration, interdisciplinary discussions, and knowledge sharing to support improved diagnosis, effective treatment, and better visual outcomes. By bringing together professionals from clinical, academic, research, and industry backgrounds, the congress seeks to strengthen professional networks, inspire future research, and contribute to the continuing advancement of ophthalmology and vision science.

Sessions

Advances in Clinical Ophthalmology and Eye Health

Clinical ophthalmology continues to evolve through improvements in diagnostic methods, treatment approaches, and patient management strategies. This session will explore current practices in the diagnosis and management of common and complex eye conditions, emphasizing early detection, evidence-based treatment, and individualized patient care. Discussions will address challenges such as delayed diagnosis, access to specialist services, disease progression, treatment adherence, and long-term monitoring. Emerging developments in digital healthcare, integrated eye care, and precision medicine will also be highlighted. Experts will share clinical experiences and research findings aimed at improving the quality, accessibility, and effectiveness of ophthalmic services.

Retinal Diseases and Macular Disorders

Retinal diseases are among the important causes of visual impairment worldwide and require accurate diagnosis, timely intervention, and appropriate long-term management. This session will focus on age-related macular degeneration, diabetic retinopathy, retinal vascular disorders, inherited retinal diseases, retinal detachment, and other macular and retinal conditions. Discussions will cover disease mechanisms, risk factors, advanced retinal imaging, biomarkers, pharmacological treatments, laser therapy, and surgical interventions. Attention will also be given to anti-VEGF therapies, emerging gene-based treatments, and personalized approaches to retinal care. Researchers and clinicians will explore strategies for improving early detection, monitoring disease progression, evaluating treatment response, and preserving visual function.

Cataract, Refractive Surgery and Lens Innovations

Cataract and refractive errors are common causes of reduced vision, and advances in surgical techniques and intraocular lens technologies continue to improve treatment options. This session will explore cataract assessment, phacoemulsification, intraocular lens selection, refractive surgery, presbyopia correction, and postoperative care. Discussions will include premium intraocular lenses, femtosecond laser-assisted procedures, surgical planning, and techniques for improving visual quality. The session will also address patient selection, surgical safety, postoperative complications, and long-term outcomes. Emerging technologies and individualized treatment planning will be considered in relation to improving patient satisfaction and achieving better visual results.

Glaucoma: Diagnosis, Monitoring and Treatment

Glaucoma is a major cause of irreversible vision loss and requires early detection and continuous monitoring to reduce the risk of disease progression. This session will examine glaucoma risk factors, intraocular pressure assessment, optic nerve evaluation, visual field testing, optical coherence tomography, and other diagnostic approaches. Discussions will cover medical management, laser treatment, surgical interventions, treatment adherence, and long-term follow-up. The role of advanced imaging, artificial intelligence, and digital monitoring in identifying disease progression and supporting clinical decisions will also be explored. Experts will discuss approaches to improving early diagnosis, preserving visual function, and strengthening patient education and ongoing glaucoma care.

Corneal Disorders, Ocular Surface Disease and Dry Eye

Corneal and ocular surface disorders can significantly affect visual function, eye comfort, and quality of life. This session will focus on corneal infections, keratoconus, corneal dystrophies, corneal injuries, dry eye disease, ocular surface inflammation, and related conditions. Discussions will cover diagnostic evaluation, corneal imaging, medical treatment, contact lens management, corneal transplantation, and emerging therapeutic options. The session will also examine advances in ocular surface research, regenerative medicine, and individualized treatment approaches. Particular attention will be given to early recognition, prevention of complications, management of chronic conditions, and improving patient comfort and visual outcomes.

Pediatric Ophthalmology and Visual Development

Pediatric ophthalmology focuses on the prevention, diagnosis, and treatment of eye conditions affecting infants, children, and adolescents. This session will explore amblyopia, strabismus, childhood refractive errors, congenital eye disorders, pediatric cataracts, and other conditions that may affect visual development. Discussions will emphasize early screening, timely intervention, appropriate treatment planning, and family education. The role of school-based vision screening, accessible pediatric eye care, and modern diagnostic tools will also be considered. Experts will share approaches to identifying childhood vision problems at an early stage and reducing the risk of long-term visual impairment through effective management and follow-up.

Neuro-Ophthalmology and Visual Pathways

Neuro-ophthalmology examines visual disorders associated with the optic nerve, brain, and visual pathways. This session will cover optic neuropathies, visual field abnormalities, pupil disorders, ocular motility disturbances, double vision, and neurological conditions that affect vision. Discussions will focus on clinical assessment, differential diagnosis, neuroimaging, electrophysiological investigations, and multidisciplinary care. The relationship between neurological diseases and visual dysfunction will also be explored, including approaches to identifying vision-related symptoms that may indicate underlying neurological conditions. Advances in diagnostic technology and research will be considered for their potential to support earlier recognition, more accurate diagnosis, and improved management of complex visual disorders.

Ocular Imaging, Biomarkers and Advanced Diagnostics

Advances in ocular imaging and diagnostic technologies are transforming the detection and monitoring of eye diseases. This session will explore optical coherence tomography, fundus photography, fluorescein angiography, corneal imaging, visual field assessment, ocular electrophysiology, and other emerging diagnostic methods. Discussions will address the use of imaging and biomarkers in identifying early disease changes, evaluating disease severity, predicting progression, and monitoring treatment response. The potential applications of molecular diagnostics, genetic testing, and data-driven analysis will also be considered. Researchers and clinicians will examine challenges related to diagnostic accuracy, reproducibility, cost, accessibility, and clinical interpretation, with the aim of improving the integration of advanced diagnostics into routine eye care.

Artificial Intelligence and Digital Technology in Ophthalmology

Artificial intelligence and digital technologies are creating new opportunities for screening, diagnosis, clinical decision support, and long-term monitoring in ophthalmology. This session will explore applications of machine learning, computer vision, automated image analysis, predictive modelling, and digital health platforms in eye care. Discussions will include AI-assisted retinal image assessment, diabetic retinopathy screening, glaucoma monitoring, disease-risk prediction, teleophthalmology, and remote consultations. The session will also address important considerations such as data quality, algorithmic bias, privacy, cyber security, transparency, and clinical validation. Experts will discuss how digital tools may support healthcare professionals, expand access to eye care, and improve the efficiency and consistency of ophthalmic services.

Ocular Therapeutics, Pharmacology and Emerging Treatments

Ocular therapeutics continues to develop through advances in pharmacology, targeted drug delivery, biologics, and innovative treatment strategies. This session will examine therapeutic approaches for retinal diseases, glaucoma, ocular surface disorders, inflammatory eye conditions, and other ophthalmic disorders. Discussions may include intravitreal treatments, sustained-release drug delivery systems, topical formulations, biologic therapies, gene-based treatments, and regenerative approaches. Attention will be given to treatment effectiveness, safety, tolerability, adherence, and access to therapies. The session will also explore emerging clinical research and the role of individualized treatment strategies in improving patient outcomes. Collaboration between clinicians, pharmacologists, researchers, and pharmaceutical professionals will be encouraged to support the development of new therapeutic options.

Ocular Genetics and Precision Ophthalmology

Genetic research is improving the understanding of inherited eye diseases and creating opportunities for more individualized approaches to ophthalmic care. This session will explore inherited retinal disorders, genetic corneal conditions, hereditary optic neuropathies, and other genetically influenced ophthalmic diseases. Discussions will cover genetic testing, molecular diagnosis, disease-risk assessment, genetic counselling, and emerging gene-based therapeutic approaches. The potential role of precision medicine in selecting treatments and predicting disease progression will also be examined. Experts will consider the clinical opportunities and challenges associated with genetic testing, including accessibility, ethical considerations, interpretation of results, and long-term follow-up. The session aims to encourage collaboration between ophthalmologists, geneticists, molecular researchers, and healthcare professionals.

Low Vision, Visual Rehabilitation and Accessible Eye Care

Low vision and visual impairment can affect independence, education, employment, mobility, and overall quality of life. This session will focus on visual rehabilitation, assistive technologies, accessible eye care services, patient counselling, and multidisciplinary support. Discussions will cover low-vision assessment, optical and electronic visual aids, orientation and mobility support, rehabilitation planning, and strategies for improving daily functioning. The role of digital accessibility tools, rehabilitation programmes, and community-based eye care will also be explored. Attention will be given to improving access to services for underserved populations and supporting individuals living with long-term visual impairment. Collaboration among ophthalmologists, optometrists, rehabilitation specialists, researchers, and community healthcare providers will be encouraged.

Vision Science and the Biology of Visual Function

Vision science provides important insights into the biological, neurological, and perceptual processes involved in visual function. This session will explore retinal physiology, photoreceptor function, visual processing, neural pathways, visual perception, eye movements, and the interaction between the visual system and the brain. Discussions will address how basic scientific discoveries can contribute to a better understanding of visual disorders and support the development of improved diagnostic and therapeutic approaches. Emerging areas such as computational vision science, visual neuroscience, advanced imaging, and experimental models of ocular disease will also be considered. The session will encourage collaboration between vision scientists, ophthalmologists, neuroscientists, engineers, and researchers working to advance the understanding of human vision.

Ocular Oncology and Eye Tumors

This session will focus on the diagnosis, treatment, and management of ocular tumors affecting different structures of the eye. Topics will include intraocular malignancies, retinal tumors, ocular melanoma, orbital tumors, advanced imaging techniques, and emerging therapeutic approaches. Emphasis will be placed on early detection, multidisciplinary care, and advancements in ocular cancer management.

Corneal Transplantation and Advanced Anterior Segment Surgery

This session will explore recent developments in corneal transplantation, advanced surgical techniques, and the management of complex anterior segment disorders. Topics will include keratoplasty, corneal tissue engineering, artificial corneas, surgical innovations, and postoperative care. The session will highlight strategies to improve graft survival, restore visual function, and enhance patient outcomes.

Ophthalmic Public Health and Global Eye Care

This session will address global challenges in eye health, including preventable blindness, access to ophthalmic services, and disparities in vision care. Topics will include community-based eye screening, public health initiatives, affordable treatment strategies, teleophthalmology, and vision care programs for underserved populations. The session will emphasize the importance of early intervention, awareness, and accessible eye care services in reducing the global burden of visual impairment.

Market Analysis

The ophthalmology and vision science sector continues to develop in response to the need for improved eye care, early diagnosis, effective treatment, and long-term management of visual disorders. The field includes hospitals, eye care centres, pharmaceutical and biotechnology companies, medical device manufacturers, diagnostic technology providers, research institutions, academic organizations, and digital health companies. Developments in retinal imaging, surgical technologies, intraocular lenses, ophthalmic medicines, and diagnostic equipment are creating new opportunities for clinical practice and research. Increasing attention to preventive eye care, the management of age-related eye conditions, and the importance of preserving visual function has also strengthened the need for continued scientific exchange and professional collaboration.

Technological innovation is an important area of development within modern ophthalmology. Artificial intelligence, teleophthalmology, advanced imaging, genetic testing, digital monitoring, and precision medicine are expanding the range of tools available for screening, diagnosis, and patient management. Pharmaceutical research and biotechnology are also exploring new therapeutic approaches, including targeted treatments, biologics, gene-based therapies, and advanced drug delivery systems. At the same time, challenges remain in relation to treatment affordability, access to specialist services, technology validation, healthcare infrastructure, and equitable delivery of eye care. Scientific conferences provide an opportunity for clinicians, researchers, healthcare organizations, and industry professionals to exchange knowledge, discuss emerging trends, and explore collaborative approaches to addressing these challenges.

Past Conference Report

Ophthalmology 2026

The 7th World Congress on Ophthalmology and Vision Science was scheduled for September 14–15, 2026, in Rome, Italy, under the theme “Future Vision Redefined: Innovations, Precision Therapies & Technological Advances in Eye Health.” The conference focused on emerging developments in ophthalmology, advancements in vision science, innovative diagnostic techniques, and modern therapeutic approaches for eye diseases. Key areas of interest included retinal disorders, glaucoma, cataract surgery, corneal diseases, pediatric ophthalmology, ocular imaging, and advancements in vision care.

The previous edition highlighted the importance of integrating precision therapies, advanced technologies, and evidence-based clinical practices to improve the diagnosis, treatment, and management of ophthalmic conditions. These topics provide a foundation for the 8th World Congress on Ophthalmology and Vision Science, scheduled for July 20–21, 2027, in Rome, Italy, which will continue to explore innovations in ophthalmic diagnostics, therapeutics, patient care, and vision science.